Product NDC: | 68828-106 |
Proprietary Name: | Jafra |
Non Proprietary Name: | Titanium Dioxide, Octinoxate |
Active Ingredient(s): | 2; 6.4 mL/80mL; mL/80mL & nbsp; Titanium Dioxide, Octinoxate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68828-106 |
Labeler Name: | Jafra Cosmetics International Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20120730 |
Package NDC: | 68828-106-02 |
Package Description: | 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01) |
NDC Code | 68828-106-02 |
Proprietary Name | Jafra |
Package Description | 10 BOTTLE in 1 PACKAGE (68828-106-02) > 8 mL in 1 BOTTLE (68828-106-01) |
Product NDC | 68828-106 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Titanium Dioxide, Octinoxate |
Dosage Form Name | LIQUID |
Route Name | TOPICAL |
Start Marketing Date | 20120730 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Jafra Cosmetics International Inc |
Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
Strength Number | 2; 6.4 |
Strength Unit | mL/80mL; mL/80mL |
Pharmaceutical Classes |